Introduction
Regulatory challenges and environmental activism in the US and EU continue to threaten the viability of EtO sterilization and will impact the supply base.
Supply of Co60 is constrained going forward as commercial powerplants undergo refurbishment and decommissioning and geopolitical pressures mount in eastern Europe.
Overall, the supply base is at or near full capacity. Without alternatives continuity of supply remains at risk and growth may be constrained.
Due to this uncertain environment, many companies initiated a conversion program to E-Beam, X-Ray or other technologies (VHP, NO2, ClO2…). How is effectiveness their conversionprogram?

Aim
The objective is to present a holistic view of a conversion program: Where to start? How to prioritize? What are the challenges? How to get adherence from the company and all functions? How communicate within the MedTech Industry? Do we have the tools to simplify and expedite studies? Can we convert all products?

Key deliverables
This presentation will cover the questions detailed in the previous section:
- Present a tool designed to help defining the scope of products and prioritisation.
- Detail the journey to convert one product family to E-Beam, describing the steps and challenges faced during the project.
- Share axes and tool to ease the conversion process and adherence in your company.